Portopulmonary hypertension: Success with combined medical treatment

Respirol Case Rep. 2023 Mar 16;11(4):e01114. doi: 10.1002/rcr2.1114. eCollection 2023 Apr.

Abstract

Portopulmonary hypertension is an uncommon disease associated with high morbidity and mortality, so its early diagnosis and treatment are essential. We report here the case of a 57-year-old man with portopulmonary hypertension caused by chronic hepatosplenic schistosomiasis and also liver cirrhosis due to hepatitis C and alcoholism. As well as treating both diseases, portopulmonary hypertension was successfully managed with tadalafil and macitentan as maintenance therapy. This case reminds clinicians that pulmonary hypertension can be multifactorial, a good diagnosis and a multidisciplinary treatment can lead to improved prognosis.

Keywords: hepatitis C; portal hypertension; portopulmonary hypertension; pulmonary hypertension; shistosomiasis.

Publication types

  • Case Reports